A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Summary

This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available in the country. The study involves multiple doses and takes place at several centers.

Timeline

Start

2025-08-12

Primary completion

2028-08

Completion

2030-08

Drugs

Indications